During the last session, Geron Corp (NASDAQ:GERN)’s traded shares were 1.48 million, with the beta value of the company hitting 0.51. At the end of the trading day, the stock’s price was $4.05, reflecting an intraday gain of 1.48% or $0.06. The 52-week high for the GERN share is $5.34, that puts it down -31.85 from that peak though still a striking 59.51% gain since the share price plummeted to a 52-week low of $1.64. The company’s market capitalization is $2.45B, and the average intraday trading volume over the past 10 days was 13.54 million shares, and the average trade volume was 8.49 million shares over the past three months.
Geron Corp (GERN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.10. GERN has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.05.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Geron Corp (NASDAQ:GERN) trade information
Geron Corp (GERN) registered a 1.48% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.48% in intraday trading to $4.05, hitting a weekly high. The stock’s 5-day price performance is 9.14%, and it has moved by -0.51% in 30 days. Based on these gigs, the overall price performance for the year is 101.45%. The short interest in Geron Corp (NASDAQ:GERN) is 76.24 million shares and it means that shorts have 11.2 day(s) to cover.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 32.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4.5 and $8 respectively. As a result, GERN is trading at a discount of -97.53% off the target high and -11.11% off the low.
Geron Corp (GERN) estimates and forecasts
Statistics show that Geron Corp has outperformed its competitors in share price, compared to the industry in which it operates. Geron Corp (GERN) shares have gone up 16.02% during the last six months, with a year-to-date growth rate more than the industry average at 21.88% against 18.00. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 44.12% this quarter and then jump 58.00% in the quarter after that. In the rating firms’ projections, revenue will increase 38,528.53% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 62.16M as predicted by 8 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 55.73M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 23k and 304k respectively. In this case, analysts expect current quarter sales to grow by 270,172.24% and then jump by 18,230.81% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -16.08%. While earnings are projected to return 17.85% in 2024, the next five years will return 5.00% per annum.
GERN Dividends
Geron Corp is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Geron Corp (NASDAQ:GERN)’s Major holders
Geron Corp insiders own 0.09% of total outstanding shares while institutional holders control 85.30%, with the float percentage being 85.37%. BLACKROCK INC. is the largest shareholder of the company, while 336.0 institutions own stock in it. As of 2024-06-30, the company held over 46.55 million shares (or 7.7138% of all shares), a total value of $197.38 million in shares.
The next largest institutional holding, with 46.2 million shares, is of RA CAPITAL MANAGEMENT, L.P.’s that is approximately 7.6558% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $195.9 million.
Also, the Mutual Funds coming in first place with the largest holdings of Geron Corp (GERN) shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 17.81 shares. This amounts to just over 2.95 percent of the company’s overall shares, with a $71.49 million market value. The same data shows that the other fund manager holds slightly less at 16.03, or about 2.65% of the stock, which is worth about $64.36 million.
